Literature DB >> 25123778

Risk factors and early origins of chronic obstructive pulmonary disease.

Dirkje S Postma1, Andrew Bush2, Maarten van den Berge3.   

Abstract

Chronic obstructive pulmonary disease is mainly a smoking-related disorder and affects millions of people worldwide, with a large effect on individual patients and society as a whole. Although the disease becomes clinically apparent around the age of 40-50 years, its origins can begin very early in life. Different risk factors in very early life--ie, in utero and during early childhood--drive the development of clinically apparent chronic obstructive pulmonary disease in later life. In discussions of which risk factors drive chronic obstructive pulmonary disease, it is important to realise that the disease is very heterogeneous and at present is largely diagnosed by lung function only. In this Review, we will discuss the evidence for risk factors for the various phenotypes of chronic obstructive pulmonary disease during different stages of life.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25123778     DOI: 10.1016/S0140-6736(14)60446-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  132 in total

Review 1.  Lung functional development and asthma trajectories.

Authors:  Fabienne Decrue; Olga Gorlanova; Jakob Usemann; Urs Frey
Journal:  Semin Immunopathol       Date:  2020-01-27       Impact factor: 9.623

2.  ERS/ATS workshop report on respiratory health effects of household air pollution.

Authors:  Akshay Sood; Nour A Assad; Peter J Barnes; Andrew Churg; Stephen B Gordon; Kevin S Harrod; Hammad Irshad; Om P Kurmi; William J Martin; Paula Meek; Kevin Mortimer; Curtis W Noonan; Rogelio Perez-Padilla; Kirk R Smith; Yohannes Tesfaigzi; Tony Ward; John Balmes
Journal:  Eur Respir J       Date:  2018-01-04       Impact factor: 16.671

3.  Office-Based Sedation/General Anesthesia for COPD Patients, Part II.

Authors:  Kristin Chino; Steven Ganzberg; Kristopher Mendoza
Journal:  Anesth Prog       Date:  2019

Review 4.  Office-Based Sedation/General Anesthesia for COPD Patients, Part I.

Authors:  Kristin Chino; Steven Ganzberg; Kristopher Mendoza
Journal:  Anesth Prog       Date:  2018

5.  A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life.

Authors:  Cristine E Berry; Dean Billheimer; Isaac C Jenkins; Zhenqiang J Lu; Debra A Stern; Lynn B Gerald; Tara F Carr; Stefano Guerra; Wayne J Morgan; Anne L Wright; Fernando D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

Review 6.  Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.

Authors:  Julio D Antuni; Peter J Barnes
Journal:  Chronic Obstr Pulm Dis       Date:  2016-06-28

7.  Long-term pulmonary complications in perinatally HIV-infected youth.

Authors:  William T Shearer; Denise L Jacobson; Wendy Yu; George K Siberry; Murli Purswani; Suzanne Siminski; Laurie Butler; Erin Leister; Gwendolyn Scott; Russell B Van Dyke; Ram Yogev; Mary E Paul; Ana Puga; Andrew A Colin; Meyer Kattan
Journal:  J Allergy Clin Immunol       Date:  2017-03-06       Impact factor: 10.793

8.  Innate Immune Responses and Pulmonary Diseases.

Authors:  Tao Liu; Siqi Liu; Xiaobo Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

10.  Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.

Authors:  Gareth R Willis; Angeles Fernandez-Gonzalez; Jamie Anastas; Sally H Vitali; Xianlan Liu; Maria Ericsson; April Kwong; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.